Serum’s HPV vaccine non-inferior to Gardasil
A phase-2/3 trial of Serum Institute of India’s human papillomavirus (HPV) vaccine Cervavac conducted at 12 tertiary care hospitals across
Read More
Vaccines
India-made typhoid vaccine efficacy lasts for four years
The efficacy of the conjugated typhoid vaccine at the end of 4.3 years of median follow-up was 70·6% for children
Read More
TB prevention: BCG revaccination study in high-risk adults to begin in 23 States
Since the government felt that a trial would take too long to complete and wanted to implement BCG revaccination at
Read More
U.S. data underscore benefits of chickenpox vaccination
Twenty-five years of data (1995-2019) from the U.S. show a sharp drop in the incidence of chickenpox and shingles in
Read More
Now a more efficacious, inexpensive malaria vaccine
The R21/MatrixM malaria vaccine developed by the University of Oxford, manufactured by the Serum Institute of India, has been recommended
Read More
FDA approves first vaccine for respiratory syncytial virus
On May 3, FDA approved the first vaccine — Arexvy — for respiratory syncytial virus (RSV) to lower respiratory tract disease in people older than 60 years
Read More
No neutralising antibodies found after Japanese encephalitis vaccination
A small trial in vaccinated children in Gorakhpur district has found seroprotection against the virus decreased sharply in fully vaccinated children
Read More
Sooner or later, India has to develop Omicron-based boosters
Vaccines based on Omicron variants are better than the ones based on the ancestral strain, but the older vaccines are still effective
Read More
More vaccine choices: On Bharat Biotech’s intranasal COVID-19 vaccine
Nearly three months after Bharat Biotech’s intranasal COVID-19 vaccine was granted emergency use approval for primary vaccination of adults, the vaccine has now
Read More
Mumbai measles outbreak due to low vaccination coverage
Evidence from elsewhere suggests that unvaccinated children have nearly 70% higher mortality risk compared with vaccinated children
Read More
Vaccine trial soon amid fear of Ebola virus spread to other countries
Currently there are no vaccines available for the Sudan strain of the Ebola virus
Read More
Corbevax booster should be a vaccine of choice
Due to faulty clinical trial design, the superiority of Corbevax heterologous booster over homologous boosters is not known On January
Read More
In haste: On vaccinating children against COVID-19
India could have waited for evidence of benefit of vaccinating all children The emergency use authorisation (EUA) granted on April 26
Read More